Aclaris Therapeutics Ownership | Who Owns Aclaris Therapeutics?


OverviewForecastRevenueFinancialsChart

Aclaris Therapeutics Ownership Summary


Aclaris Therapeutics is owned by 74.93% institutional investors, 2.69% insiders, and 22.38% retail investors. Bml capital management is the largest institutional shareholder, holding 11.62% of ACRS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.93% of its assets in Aclaris Therapeutics shares.

ACRS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAclaris Therapeutics74.93%2.69%22.38%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryDiagnostics & Research Stocks56.55%10.64%32.81%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bml capital management14.25M11.63%$20.23M
Adage capital partners gp9.63M7.85%$13.67M
Vivo capital8.89M7.25%$12.62M
Vanguard group4.33M6.06%$10.73M
D. e. shaw3.29M4.61%$8.17M
Blackrock funding, inc. /de5.51M4.50%$7.83M
Rock springs capital management lp4.77M3.89%$6.77M
Decheng capital4.04M3.30%$5.74M
Blackrock2.03M2.86%$2.24M
Millennium management1.96M2.74%$4.86M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management14.25M15.31%$20.23M
Decheng capital4.04M1.45%$5.74M
Aldebaran capital993.70K1.39%$1.41M
Vivo capital8.89M1.29%$12.62M
Stonepine capital management491.30K0.68%$697.65K
Rock springs capital management lp4.77M0.42%$6.77M
Palo alto investors lp1.39M0.42%$1.97M
Logos global management lp1.85M0.29%$2.63M
Aisling capital management lp434.45K0.17%$616.93K
Velan capital investment management lp27.00K0.06%$66.96K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de5.51M0.00%4.15M
Palo alto investors lp1.39M0.42%614.00K
Acadian asset management2.43M0.01%238.66K
Dimensional fund advisors lp239.59K0.00%162.78K
Squarepoint ops292.89K0.00%152.31K

Top Sellers

HolderShares% AssetsChange
Ra capital management---4.67M
Blackrock2.03M0.00%-3.17M
Janus henderson group---2.80M
Samsara biocapital---2.39M
Trium capital llp---1.91M

New Positions

HolderShares% AssetsChangeValue
Intech investment management44.73K0.00%44.73K$63.52K
Velan capital investment management lp27.00K0.06%27.00K$66.96K
Cra financial services17.78K0.00%17.78K$25.25K
Virtu financial11.62K0.00%11.62K$13.00K
Invesco11.21K-11.21K$27.81K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-14.00
Innealta capital-56.00
Cornerstone planning group-580.00
New york state common retirement fund-586.00
Mai capital management-1.50K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202595-12.04%91,849,9067.52%741.54%56-9.68%25-
Mar 31, 20251106.80%92,692,4785.96%750.50%626.90%264.00%
Dec 31, 202410328.75%87,478,91971.89%1222.41%5881.25%25-
Sep 30, 202480-15.79%50,891,462-3.68%711.29%33-19.51%25-32.43%
Jun 30, 202495-3.06%52,834,184-2.94%741.26%41-4.65%37-5.13%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.18M2.93%-70.07K
Vanguard US Total Market Shares ETF2.12M1.96%-
iShares Russell 2000 ETF1.78M1.65%-33.91K
Vanguard Institutional Extnd Mkt Idx Tr1.22M1.13%-555.76K
Xtrackers S&P 500 Swap ETF 1C923.31K0.85%-
iShares Russell 2000 Value ETF782.60K0.72%581.00
SQUAD Aguja Opportunities I500.00K0.70%-
Vanguard Strategic Small-Cap Equity Inv592.57K0.55%-
Fidelity Extended Market Index584.07K0.54%-1.52K
Vanguard Russell 2000 ETF434.47K0.40%-27.61K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 19, 2024Mehra Anand-Buy$1.50M
Aug 05, 2024Leonard Braden Michael-Buy$256.36K
Aug 02, 2024Leonard Braden Michael-Buy$216.40K
Jul 30, 2024Leonard Braden Michael-Buy$226.37K
Jul 31, 2024Leonard Braden Michael-Buy$132.64K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q41-
2024 Q311-
2024 Q210-

ACRS Ownership FAQ


Who Owns Aclaris Therapeutics?

Aclaris Therapeutics shareholders are primarily institutional investors at 74.93%, followed by 2.69% insiders and 22.38% retail investors. The average institutional ownership in Aclaris Therapeutics's industry, Diagnostics & Research Stocks, is 56.55%, which Aclaris Therapeutics exceeds.

Who owns the most shares of Aclaris Therapeutics?

Aclaris Therapeutics’s largest shareholders are Bml capital management (14.25M shares, 11.62%), Adage capital partners gp (9.63M shares, 7.85%), and Vivo capital (8.89M shares, 7.25%). Together, they hold 26.73% of Aclaris Therapeutics’s total shares outstanding.

Does Blackrock own Aclaris Therapeutics?

Yes, BlackRock owns 2.86% of Aclaris Therapeutics, totaling 2.03M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 2.24M$. In the last quarter, BlackRock decreased its holdings by -3.17M shares, a -60.94% change.

Who is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.31% of its assets in 14.25M Aclaris Therapeutics shares, valued at 20.24M$.

Who is the top mutual fund holder of Aclaris Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aclaris Therapeutics shares, with 2.93% of its total shares outstanding invested in 3.18M Aclaris Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools